151 related articles for article (PubMed ID: 36672487)
1. Dual Function of CCAT2 in Regulating Luminal Subtype of Breast Cancer Depending on the Subcellular Distribution.
Xie H; Guo Y; Xu Z; Wang Q; Wang T; Gu Y; Li D; Liu Y; Ma W; Liu P; Zhao Q; Lü J; Liu J; Yu Z
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672487
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.
Xu Z; Liu C; Zhao Q; Lü J; Ding X; Luo A; He J; Wang G; Li Y; Cai Z; Wang Z; Liu J; Liu S; Li W; Yu Z
Pharmacol Res; 2020 Feb; 152():104628. PubMed ID: 31904506
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway.
Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713
[TBL] [Abstract][Full Text] [Related]
5. piRNA-823 Is Involved in Cancer Stem Cell Regulation Through Altering DNA Methylation in Association With Luminal Breast Cancer.
Ding X; Li Y; Lü J; Zhao Q; Guo Y; Lu Z; Ma W; Liu P; Pestell RG; Liang C; Yu Z
Front Cell Dev Biol; 2021; 9():641052. PubMed ID: 33791297
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway.
Cai Y; He J; Zhang D
Onco Targets Ther; 2015; 8():2657-64. PubMed ID: 26442763
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells.
Yu Y; Nangia-Makker P; Farhana L; Majumdar APN
Mol Cancer; 2017 Sep; 16(1):155. PubMed ID: 28964256
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA CCAT2 Promotes the Development of Esophageal Squamous Cell Carcinoma by Inhibiting miR-200b to Upregulate the IGF2BP2/TK1 Axis.
Wu X; Fan Y; Liu Y; Shen B; Lu H; Ma H
Front Oncol; 2021; 11():680642. PubMed ID: 34386421
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis.
Zhou N; Si Z; Li T; Chen G; Zhang Z; Qi H
Oncol Lett; 2016 Jul; 12(1):132-138. PubMed ID: 27347113
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
11. Effect of long noncoding RNA CCAT2 on drug sensitivity to 5-fluorouracil of breast cancer cells through microRNA-145 meditated by p53.
Zhang Z; Wang X; Wang Y; Zhou D; Wu H; Cheng W; Wang Q; Zheng G; Wang J; Gu J
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23176. PubMed ID: 35968984
[TBL] [Abstract][Full Text] [Related]
12. CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 cells.
Moradi F; Mohajerani F; Sadeghizadeh M
Life Sci; 2022 Dec; 311(Pt B):121183. PubMed ID: 36375570
[TBL] [Abstract][Full Text] [Related]
13. Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis.
Wang J; Liu Y; Cai H; Jiang H; Li W; Shi Y
Bioengineered; 2021 Dec; 12(1):6264-6274. PubMed ID: 34499007
[TBL] [Abstract][Full Text] [Related]
14. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
15. A positive feedback loop of long noncoding RNA CCAT2 and FOXM1 promotes hepatocellular carcinoma growth.
Chen F; Bai G; Li Y; Feng Y; Wang L
Am J Cancer Res; 2017; 7(7):1423-1434. PubMed ID: 28744394
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424.
Sun SL; Shu YG; Tao MY
Mol Cell Biochem; 2020 May; 468(1-2):69-82. PubMed ID: 32236863
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CCAT2 reduces chemosensitivity to 5-fluorouracil in breast cancer cells by activating the mTOR axis.
Zhou D; Gu J; Wang Y; Luo B; Feng M; Wang X
J Cell Mol Med; 2022 Mar; 26(5):1392-1401. PubMed ID: 35170195
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
Zhang Z; Sun L; Zhang Y; Lu G; Li Y; Wei Z
J Cell Physiol; 2018 Nov; 233(11):8630-8638. PubMed ID: 29797562
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2.
Wang YJ; Liu JZ; Lv P; Dang Y; Gao JY; Wang Y
Am J Cancer Res; 2016; 6(11):2651-2660. PubMed ID: 27904778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
